Business News • PR NewsWire • SPI Pharma Expands Mannogem® Mannitol Product Portfolio to support the development, manufacture and administration of oral dosage forms.

SPI Pharma Expands Mannogem® Mannitol Product Portfolio to support the development, manufacture and administration of oral dosage forms.

SPI Pharma Expands Mannogem® Mannitol Product Portfolio to support the development, manufacture and administration of oral dosage forms.

WILMINGTON, Del., March 24, 2020 /PRNewswire/ -- SPI Pharma has announced an expansion of its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Mannogem XL Opal, Mannogem XL Ruby, Mannogem Emerald, and Mannogem Onyx. SPI Pharma has...

View More : https://www.prnewswire.com:443/news-releases/spi-pharma-expands-mannogem-mannitol-product-portfolio-to-support-the-devel...

Releted News by prnewswire

Keio University Research: Sleep and the Social Competence of Children

National Museum of Art, Osaka, Announces Exhibition Schedule of 2020

PSEG Donates 50,000 N95 Masks to Aid Response by Health Care and First Responders During COVID-19 Pandemic

Aaron's, Inc. Donates Computers To Atlanta Children For COVID-19 Distance Learning